Hetero and Dr Reddy’s — will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot, lenacapavir, for $40 (around R692) per person per ...

A new long-acting medicine that could make preventing HIV transition might soon be even for poor countries like Uganda thanks to agreements between producers and key HIV/AIDS prevention programme ...

Without clear timelines and accountability, Ireland risks falling short of its goal to end new HIV transmissions by 2030.

A long-acting HIV jab promises near-perfect protection at just $40 a year, but 115 nations must wait for India's approval of ...

According to the World Health Organization (WHO), lenacapavir offers a highly effective, long-acting alternative to daily ...

Cork and Kerry share one HIV clinic, which is 'stretched', Cork Sexual Health Centre's fast-track cities programme manager ...

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even ...

New HIV transmissions can be ended, but political will is needed, according to HIV Ireland. The first national HIV conference opens in the Aisling Hotel Dublin today.

Attributing the rise in infections to increased testing, health officials said around 23 percent of those potentially living with HIV remain unaware of their health status.

Nigeria has secured a landmark agreement to drastically cut the cost of a revolutionary HIV prevention drug, lenacapavir, paving the way for millions of citizens to access the life-saving medicine and ...

Lupin Ltd has received tentative approval from the US FDA for its generic version of HIV treatment Bictegravir, Emtricitabine ...